Christopher Maxwell

Professor

The University of British Columbia

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christopher Maxwell is a Professor at the University of British Columbia, Canada. His research primarily focuses on cancer genomics and proteomics, with recent publications addressing the risk of breast cancer in BRCA1 pathogenic variant carriers, as well as treatment pathways for pediatric acute lymphoblastic leukemia and neuroblastoma. His work includes the development of novel animal models and exploration of molecular targets relevant to malignancies in children.

Articles (12)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (10)

Raymond H. Kim

University Health Network

CANADA

View details

Curtis W. McCloskey

Assistant Professor

UPMC Hillman Cancer Center

UNITED STATES

View details

Nagarajan Kannan

Assistant Professor

Mayo Clinic

UNITED STATES

View details

Jennifer Chan

Broad Institute

UNITED STATES

View details

Connie Eaves

Professor

The University of British Columbia

CANADA

View details

Andrea Eisen

McMaster University

CANADA

View details

Philipp Lange

Assistant Professor & Canada Research Chair

The University of British Columbia

CANADA

View details

Chinten James Lim

Associate Professor

The University of British Columbia

CANADA

View details

Razqallah Hakem

Full Professor

University of Toronto

CANADA

View details

Gregor Reid

Associate Professor

The University of British Columbia

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christopher Maxwell

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe

Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant

The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia.

ATAD1 prevents clogging of TOM and damage caused by un-imported mitochondrial proteins.

Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia

Adaptation of the Th-MYCN Mouse Model of Neuroblastoma for Evaluation of Disseminated Disease

Modification of BRCA1-associated breast cancer risk by HMMR overexpression

Centrosome Amplification Is a Potential Molecular Target in Paediatric Acute Lymphoblastic Leukemia.

A cross‐standardized flow cytometry platform to assess phenotypic stability in precursor B‐cell acute lymphoblastic leukemia (B‐ALL) xenografts

Pathogenic BRCA1 variants disrupt PLK1-regulation of mitotic spindle orientation

PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways

Diet as a Potential Moderator for Genome Stability and Immune Response in Pediatric Leukemia

Collaborators (10)

Raymond H. Kim

Curtis W. McCloskey

Nagarajan Kannan

Jennifer Chan

Connie Eaves

Andrea Eisen

Philipp Lange

Chinten James Lim

Razqallah Hakem

Gregor Reid

Make your next move.